• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物制剂治疗 Hallopeau 连续性肢端皮炎:司库奇尤单抗治疗有效并文献复习

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.

机构信息

Dermatology Unit, University of Rome "Tor Vergata", Rome, Italy.

出版信息

Dermatol Ther. 2019 May;32(3):e12899. doi: 10.1111/dth.12899. Epub 2019 Apr 29.

DOI:10.1111/dth.12899
PMID:30969010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6618131/
Abstract

Acrodermatitis continua of Hallopeau (ACH) is a rare pustular psoriasis variant refractory to many conventional treatments. We report the successful treatment with secukinumab of a patient with a long history of ACH with marked onychodystrophy with frank pustulosis on the nail bed and with accompanying arthritis. Blockade of the IL-17 receptor A has shown promise in the treatment of psoriatic erythroderma and generalized pustular psoriasis not responsive to conventional treatment. A rapid response was observed in our patient, in both skin lesions and arthritic symptoms, underlining the ability of secukinumab to improve symptoms beyond those of plaque psoriasis.

摘要

Hallopeau 连续性肢端皮炎(ACH)是一种罕见的脓疱性银屑病变种,对许多传统治疗方法有抗药性。我们报告了一例 ACH 病史长、伴有明显甲营养不良、甲床有明显脓疱病且伴有关节炎的患者,使用司库奇尤单抗治疗获得成功。IL-17 受体 A 阻断剂在治疗对常规治疗无反应的银屑病红皮病和泛发性脓疱性银屑病方面显示出良好的疗效。我们的患者在皮肤病变和关节炎症状方面均迅速得到改善,这突出了司库奇尤单抗除改善斑块状银屑病外,还能改善症状的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d6/6618131/6253c729a97c/DTH-32-na-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d6/6618131/41d31f33aad4/DTH-32-na-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d6/6618131/036f1d93a9c9/DTH-32-na-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d6/6618131/6253c729a97c/DTH-32-na-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d6/6618131/41d31f33aad4/DTH-32-na-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d6/6618131/036f1d93a9c9/DTH-32-na-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d6/6618131/6253c729a97c/DTH-32-na-g003.jpg

相似文献

1
Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.生物制剂治疗 Hallopeau 连续性肢端皮炎:司库奇尤单抗治疗有效并文献复习
Dermatol Ther. 2019 May;32(3):e12899. doi: 10.1111/dth.12899. Epub 2019 Apr 29.
2
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.司库奇尤单抗成功治疗合并泛发性脓疱型银屑病的Hallopeau连续性肢端皮炎:一例报告
Front Immunol. 2024 Feb 23;15:1338285. doi: 10.3389/fimmu.2024.1338285. eCollection 2024.
3
Treatment of acrodermatitis continua of hallopeau with ixekizumab.以依奇珠单抗治疗 Hallopeau 连续性肢端皮炎。
J Dermatolog Treat. 2021 Feb;32(1):117-119. doi: 10.1080/09546634.2019.1628170. Epub 2019 Jul 5.
4
The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.生物疗法在 Hallopeau 连续性肢端皮炎治疗中的应用:综述。
J Cutan Med Surg. 2019 Jul/Aug;23(4):428-435. doi: 10.1177/1203475419836435. Epub 2019 Apr 2.
5
Acrodermatitis continua of Hallopeau successfully treated with secukinumab.司库奇尤单抗成功治疗Hallopeau连续性肢端皮炎。
J Dermatolog Treat. 2018;29(sup1):3-5. doi: 10.1080/09546634.2018.1527993.
6
Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.Hallopeau 连续性肢端皮炎(ACH):阿达木单抗成功治疗两例。
J Dermatolog Treat. 2014 Dec;25(6):489-94. doi: 10.3109/09546634.2013.848259. Epub 2013 Nov 12.
7
Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau.不同类型治疗方法对顽固性Hallopeau连续性肢端皮炎患者的疗效。
Biologics. 2019 May 20;13:83-87. doi: 10.2147/BTT.S199100. eCollection 2019.
8
Plaque psoriasis, generalized pustular psoriasis, palmoplantar pustulosis, and acrodermatitis continua of Hallopeau successfully treated with bimekizumab: a promising therapeutic approach.用比美吉珠单抗成功治疗斑块状银屑病、泛发性脓疱型银屑病、掌跖脓疱病和Hallopeau连续性肢端皮炎:一种有前景的治疗方法。
Eur J Dermatol. 2024 Aug 1;34(4):448-449. doi: 10.1684/ejd.2024.4751.
9
Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.伴有银屑病关节炎的Hallopeau连续性肢端皮炎
J Rheumatol. 2019 Apr;46(4):437-438. doi: 10.3899/jrheum.180086.
10
[Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].[哈洛佩au连续性肢端皮炎与银屑病关节炎:一例报告]
Medwave. 2020 Sep 17;20(8):e8021. doi: 10.5867/medwave.2020.08.8021.

引用本文的文献

1
Acrodermatitis continua of Hallopeau: a review and update on biological and small molecule targeted immunomodulatory therapies.哈洛佩奥连续性肢端皮炎:生物和小分子靶向免疫调节疗法的综述与更新
Front Immunol. 2025 Aug 15;16:1525821. doi: 10.3389/fimmu.2025.1525821. eCollection 2025.
2
Epidemiological, Genetic, Clinical, and Treatment Differences of Generalized Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Across Ethnicities: A Systematic Review.泛发性脓疱型银屑病和Hallopeau连续性肢端皮炎在不同种族间的流行病学、遗传学、临床及治疗差异:一项系统综述
Am J Clin Dermatol. 2025 May;26(3):395-409. doi: 10.1007/s40257-025-00937-9. Epub 2025 Apr 1.
3

本文引用的文献

1
Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.司库奇尤单抗:一种用于治疗银屑病的抗白细胞介素-17A生物制剂的综述。
Ther Adv Chronic Dis. 2018 Jan;9(1):5-21. doi: 10.1177/2040622317738910. Epub 2017 Nov 16.
2
Pustular psoriasis and related pustular skin diseases.脓疱型银屑病及相关脓疱性皮肤病。
Br J Dermatol. 2018 Mar;178(3):614-618. doi: 10.1111/bjd.16232. Epub 2018 Jan 15.
3
Unopposed IL-36 Activity Promotes Clonal CD4 T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis.
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
司库奇尤单抗成功治疗合并泛发性脓疱型银屑病的Hallopeau连续性肢端皮炎:一例报告
Front Immunol. 2024 Feb 23;15:1338285. doi: 10.3389/fimmu.2024.1338285. eCollection 2024.
4
The Current Advancement in Psoriasis.银屑病的当前进展
Cureus. 2023 Oct 13;15(10):e47006. doi: 10.7759/cureus.47006. eCollection 2023 Oct.
5
Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.用比美吉珠单抗成功治疗的哈洛佩奥连续性肢端皮炎:一例报告
SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160937. doi: 10.1177/2050313X231160937. eCollection 2023.
无拮抗的 IL-36 活性促进全身性脓疱性银屑病中具有 IL-17A 产生的克隆 CD4 T 细胞应答。
J Invest Dermatol. 2018 Jun;138(6):1338-1347. doi: 10.1016/j.jid.2017.12.024. Epub 2017 Dec 27.
4
European consensus statement on phenotypes of pustular psoriasis.欧洲脓疱型银屑病表型共识声明。
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1792-1799. doi: 10.1111/jdv.14386. Epub 2017 Aug 29.
5
Interleukin-17 blockade in generalized pustular psoriasis - new hope for severely ill patients.白介素-17阻断剂治疗泛发性脓疱型银屑病——重症患者的新希望
Br J Dermatol. 2017 Mar;176(3):572-573. doi: 10.1111/bjd.14987.
6
Brodalumab for the treatment of psoriasis.布罗达单抗治疗银屑病。
Expert Rev Clin Immunol. 2016 Dec;12(12):1255-1271. doi: 10.1080/1744666X.2016.1246957. Epub 2016 Oct 21.
7
Secukinumab: A Review in Psoriatic Arthritis.司库奇尤单抗:治疗银屑病关节炎的研究进展。
Drugs. 2016 Jul;76(11):1135-45. doi: 10.1007/s40265-016-0602-3.
8
Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study.在泛发性脓疱型银屑病和红皮病型银屑病患者中,布罗达umab 的疗效和安全性:一项为期 52 周、开放标签研究的结果。
Br J Dermatol. 2017 Mar;176(3):741-751. doi: 10.1111/bjd.14702. Epub 2016 Oct 2.
9
New and emerging therapies in psoriasis.银屑病的新型及新兴疗法
Semin Cutan Med Surg. 2014 Mar;33(2 Suppl 2):S37-41. doi: 10.12788/j.sder.0066.
10
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.泛发性脓疱型银屑病的遗传背景:IL36RN突变和CARD14功能获得性变体。
J Dermatol Sci. 2014 Jun;74(3):187-92. doi: 10.1016/j.jdermsci.2014.02.006. Epub 2014 Mar 5.